EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · IEX Real-Time Price · USD
8.69
-0.32 (-3.55%)
At close: Jun 18, 2024, 4:00 PM
8.30
-0.39 (-4.49%)
After-hours: Jun 18, 2024, 7:39 PM EDT

EyePoint Pharmaceuticals Revenue

EyePoint Pharmaceuticals had revenue of $50.02M in the twelve months ending March 31, 2024, with 25.70% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $11.68M with 52.08% year-over-year growth. In the year 2023, EyePoint Pharmaceuticals had annual revenue of $46.02M with 11.14% growth.

Revenue (ttm)
$50.02M
Revenue Growth
+25.70%
P/S Ratio
9.05
Revenue / Employee
$413,380
Employees
121
Market Cap
452.61M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202346.02M4.61M11.14%
Dec 31, 202241.40M4.47M12.09%
Dec 31, 202136.94M2.50M7.27%
Dec 31, 202034.44M14.07M69.10%
Dec 31, 201920.37M17.40M587.77%
Jun 30, 20182.96M-4.58M-60.72%
Jun 30, 20177.54M5.92M365.37%
Jun 30, 20161.62M-24.95M-93.90%
Jun 30, 201526.57M23.09M664.90%
Jun 30, 20143.47M1.33M62.06%
Jun 30, 20132.14M-1.38M-39.22%
Jun 30, 20123.53M-1.44M-28.98%
Jun 30, 20114.97M-18.09M-78.46%
Jun 30, 201023.05M10.89M89.55%
Jun 30, 200912.16M8.69M249.88%
Jun 30, 20083.48M1.69M94.73%
Jun 30, 20071.79M749.00K72.30%
Jun 30, 20061.04M909.64K719.88%
Jun 30, 2005126.36K-171.35K-57.56%
Jun 30, 2004297.71K211.38K244.87%
Jun 30, 200386.33K-628.62K-87.93%
Jun 30, 2002714.95K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition